70 likes | 215 Views
Research without borders. Supporting research and patient outreach for FacioScapulo -Humeral Muscular Dystrophy (FSHD), the most prevalent form of muscular dystrophy.
E N D
Research without borders Supporting research and patient outreach for FacioScapulo-Humeral Muscular Dystrophy (FSHD), the most prevalent form of muscular dystrophy. Progress on FSHD could benefit a wide range of other areas of medicine, from cancer and diabetes to muscle regeneration and repair.
What is FSHD? • FSH Muscular Dystrophy (FSHD) is caused by a genetic defect, one that is passed down from parent to child but can also arise spontaneously. It can affect anyone. • An estimated 500,000 people worldwide have FSHD, and 1-2% of the population carries a risk gene. • The disease attacks all skeletal muscles – typically affecting the face, shoulders, arms, back and legs. • Symptoms may be evident at birth or during childhood, but more often appear during teenage and adult years. • FSHD can be profoundly disabling, causing a loss of facial expression, difficulties with speech and hearing, and an inability to lift objects or walk.
What the FSH Society has Accomplished • Created a global research program when none existed, by recruiting and funding scientists to undertake FSHD research. • Persuaded the U.S. government to allocate funding to FSHD research. • Convened international research meetings to coordinate a global campaign to cure FSHD. • Funded work leading to the discovery of FSHD genes and paving the way to potential treatments. • Empowered a worldwide network of patients and families through education, peer-to-peer support and access to care.
Scientific Breakthroughs Made Possible by FSH Society Funding • The discovery of a specific genetic “package” called DUX4 that is associated with most cases of FSHD. • The successful reversal of FSHD symptoms in mice using gene therapy (RNAi). • The identification of genes and proteins that damage muscle cells, as well as the mechanisms that can cause the disease. • Developed FSHD cell lines and animal models to test hypotheses and potential treatments.
Why Your Support is Critical • With enough funding, we could have the first effective FSHD treatments in the next 5-10 years. • NIH budget cuts are slowing down progress. Top scientists spend more time writing grants instead of working in the lab. • Without enough grants, some may have to stop their research, jeopardizing years of public and private investment in their work. • We cannot afford to slow down. Patients need treatments in their lifetimes! • FSHD research may help in other areas of medicine, from cancer to diabetes as well as other muscle-wasting disease that are more common.
Give with Confidence FSH Canada Foundation partners with the FSH Society to direct funding to the world’s best research, guided by the Society’s world-renowned Scientific Advisory Board. The FSH Society has earned its fourth consecutive 4-star Charity Navigator rating, awarded to charities that outperform the majority of organizations. Eighty-seven percent of the revenue raised by the Society goes directly to research and education.